In contrast, the demethylase FTO is highly expressed in multiple subtypes of AML, especially upregulated in AML with MLL rearrangements, compared with normal controls and AML with non-MLL-rearrangements. The gene discussed is KMT2A; the disease is acute myeloid leukemia.